MedPath

温州海鹤药业有限公司

Ownership
-
Established
2001-03-27
Employees
-
Market Cap
-
Website
http://www.wzhaihe.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

49

NMPA:49

Drug Approvals

Compound α-Ketoacid Tablets

Product Name
复方α-酮酸片
Approval Number
国药准字H20253204
Approval Date
Jan 14, 2025
NMPA

Lanthanum Carbonate Chewable Tablets

Product Name
碳酸镧咀嚼片
Approval Number
国药准字H20244505
Approval Date
Jul 30, 2024
NMPA

Ibuprofen Arginine Granules

Product Name
精氨酸布洛芬颗粒
Approval Number
国药准字H20244028
Approval Date
Jun 18, 2024
NMPA

Acetylcysteine Solution for Inhalation

Product Name
吸入用乙酰半胱氨酸溶液
Approval Number
国药准字H20243692
Approval Date
May 15, 2024
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20123272
Approval Date
May 29, 2023
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20080742
Approval Date
May 22, 2023
NMPA

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20233213
Approval Date
Feb 21, 2023
NMPA

周公百岁酒

Approval Number
国药准字Z33020736
Approval Date
Mar 10, 2022
NMPA

三两半药酒

Approval Number
国药准字Z33020995
Approval Date
Mar 10, 2022
NMPA

暖胃舒乐片

Approval Number
国药准字Z20073172
Approval Date
May 10, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.